A Dutch-British contract research organisation (CRO) is specialized in biological and analytical preclinical testing of novel drugs. The CRO is in particular highly specialised in immunology research and offers standard and customized biological and analytical assays for preclinical drug development. The company specialises in designing, developing and experimenting preclinical models to study immune response, immune risk and biological interactions.
Immune modelling is the modelling of a system to test the immune response that may be associated with a drug, an infection or a metabolite. To support drug developing companies, the CRO provides various immunologic, in vitro, protein based and bioanalytical assays using cell lines and primary cells. These are provided either as standard assays or as custom designed assays. Through their defined assays they help pharma companies and institutes to study drug impact on immune response, protein expression, cell to cell interaction, migration, proliferation, cell death and cytotoxicity, functional assays using gene knockdown, lymphocyte functions, cytokine expressions, etc.
The company is fast growing and recently opened a new laboratory facility in the UK. The CRO is now looking for commercial agents to support their sales activities. A commercial agency agreement is envisioned.